Biomarker Study in Colorectal and Gastric Cancer Surgery
Part of Cancer, Digestive system, Infections clinical trials.
This study looks at blood markers before and after surgery for colorectal or stomach cancer. The goal is to understand how these markers change and what they might tell us about recovery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have colorectal cancer or stomach cancer.
- You are scheduled for planned (not emergency) surgery to remove the cancer.
- You are in good enough health for surgery (classified as ASA II to IV).
- You are willing to give written permission to join the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at colorectal cancer patients who are planning curative surgery and collects related outcomes and lab “biomarker” information to better understand the disease. Your participation may help researchers connect test results to treatment results over time.
This study tests if a simple blood test can detect early signs of colorectal cancer coming back after surgery to remove cancer spread in the abdomen. It may help patients avoid unnecessary treatments and catch recurrence sooner.
This study checks blood and other lab “biomarkers” during the time before and after major surgeries to see if they can help guide perioperative care. You might be eligible if you are having certain planned heart, lung, GI, or blood-vessel surgeries and can give informed consent.
This study looks at special tiny cell-signal particles (called exosomes) and related pathways to understand colorectal cancer. Your results from samples may help researchers learn how these signals relate to the disease after surgery.
This study looks at whether tracking early recovery signs after major gastrointestinal surgery can help identify patients at higher risk for complications.
This study looks at blood proteins and other health signs before surgery to see if they can predict complications after colon or rectal cancer surgery. It might help doctors plan better care for patients.
Hear when a new Colorectal (Colon or Rectal) Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.